| New Assessment System in Measuring Symptom Distress in Cancer Patients |
Interview, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
| Neuropsychological and Behavioral Testing in Younger Patients With Cancer |
Cognitive Assessment, Quality-of-Life Assessment |
Recruiting |
| Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer |
Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Olanzapine, Placebo, Prochlorperazine, Quality-of-Life Assessment |
Recruiting |
| Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer |
Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim, Surgical Procedure |
Active, not recruiting |
| NCI COVID-19 in Cancer Patients, NCCAPS Study |
Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Natural Berry Extract Treatment of Hemangiomas |
PediaBerry |
Recruiting |
| National Cancer Institute "Cancer Moonshot Biobank" |
Biospecimen Collection, Medical Chart Review |
Recruiting |
| Nashville Early Diagnosis Lung Cancer Project |
Computerized tomography (CT) scan of the chest, Pulmonary function tests, Nasal brushings, Urine sample, Bronchoscopy, Blood sample collection, Bronchoalveolar lavage, Questionnaire-data collection, Buccal epithelium collection, Sputum sample |
Active, not recruiting |
| Naltrexone Treatment for Prolonged Grief Disorder (PGD) |
Placebo, Naltrexone HCl 50 MG Oral Tablet |
Recruiting |
| Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer |
Naloxegol, Placebo, Laboratory Biomarker Analysis, Quality-of-Life Assessment |
Active, not recruiting |